{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:51:41Z","timestamp":1791395501135,"version":"4.3.3"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Digit. Health"],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To investigate whether voxel-based prostate volume can improve the diagnostic performance of prostate-specific antigen density (PSAD) for detecting clinically significant prostate cancer (csPCa) in patients within the prostate-specific antigen (PSA) gray zone (4\u201310\u2005ng\/mL), and to compare it with conventional formula-based estimation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this retrospective study, 489 patients with PSA levels of 4\u201310\u2005ng\/mL who underwent prostate MRI were included. Prostate volumes were calculated using three methods ellipsoid formula (\n                      <jats:italic>\n                        PV\n                        <jats:sub>formula<\/jats:sub>\n                      <\/jats:italic>\n                      ), manual voxel-based segmentation (\n                      <jats:italic>\n                        PV\n                        <jats:sub>mask<\/jats:sub>\n                      <\/jats:italic>\n                      ), and automated voxel-based segmentation (\n                      <jats:italic>\n                        PV\n                        <jats:sub>auto_seg<\/jats:sub>\n                      <\/jats:italic>\n                      ) based on nnU-Net. Agreement between volumetric measurements was assessed using Bland\u2013Altman analysis, and PSAD was calculated according to three prostate volume estimations. Diagnostic performance for the detection of csPCa was evaluated using receiver operating characteristic (ROC) analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>\n                        PV\n                        <jats:sub>formula<\/jats:sub>\n                      <\/jats:italic>\n                      systematically overestimated prostate volume compared with\n                      <jats:italic>\n                        PV\n                        <jats:sub>mask<\/jats:sub>\n                      <\/jats:italic>\n                      , with mean volumes of 58.8\u2009\u00b1\u200928.1\u2005mL and 54.5\u2009\u00b1\u200926.6\u2005mL (bias 4.4\u2005mL); whereas\n                      <jats:italic>\n                        PV\n                        <jats:sub>auto_seg<\/jats:sub>\n                      <\/jats:italic>\n                      (55.8\u2009\u00b1\u200920.8\u2005mL) showed close agreement with\n                      <jats:italic>\n                        PV\n                        <jats:sub>mask<\/jats:sub>\n                      <\/jats:italic>\n                      and reduced bias of 1.4\u2005mL. In ROC analysis, voxel-based\n                      <jats:italic>\n                        PSAD\n                        <jats:sub>mask<\/jats:sub>\n                      <\/jats:italic>\n                      (AUC 0.762, 95% CI 0.717\u20130.808) outperformed the formula-based\n                      <jats:italic>\n                        PSAD\n                        <jats:sub>formula<\/jats:sub>\n                      <\/jats:italic>\n                      (AUC 0.719, 95% CI 0.671\u20130.767;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.01).\n                      <jats:italic>\n                        PSAD\n                        <jats:sub>auto_seg<\/jats:sub>\n                      <\/jats:italic>\n                      calculated from\n                      <jats:italic>\n                        PV\n                        <jats:sub>auto_seg<\/jats:sub>\n                      <\/jats:italic>\n                      yielded an AUC similar (0.754, 95% CI 0.707\u20130.800) to that of with\n                      <jats:italic>\n                        PSAD\n                        <jats:sub>mask<\/jats:sub>\n                      <\/jats:italic>\n                      , and also outperformed\n                      <jats:italic>\n                        PSAD\n                        <jats:sub>formula<\/jats:sub>\n                      <\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.02).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Voxel-based prostate volumetry provides more accurate and consistent volume estimation than the conventional ellipsoid formula, leading to improved PSAD performance for detecting csPCa in the PSA gray zone. Moreover, automated segmentation enables reliable and scalable PSAD calculation with diagnostic performance comparable to manual delineation, supporting its potential for clinical implementation in risk stratification of PCa.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fdgth.2026.1897681","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:00:15Z","timestamp":1791392415000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Automated voxel-based prostate volumetry improves PSA density\u2013based detection of clinically significant prostate cancer in the PSA gray zone: comparison with manual segmentation and the ellipsoid formula"],"prefix":"10.3389","volume":"8","author":[{"given":"Jing","family":"Han","sequence":"first","affiliation":[{"name":"Department of Radiology, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Suzhou, China"]},{"name":"Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Suzhou, China"]},{"name":"Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houdong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Jiangsu Medical College","place":["Yancheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Jiangsu Medical College","place":["Yancheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: gLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1056\/NEJMcp2209151","article-title":"Screening for prostate cancer","volume":"388","author":"Pinsky","year":"2023","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"424","DOI":"10.5694\/mja2.51722","article-title":"Modern paradigms for prostate cancer detection and management","volume":"217","author":"Williams","year":"2022","journal-title":"Med J Aust"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","article-title":"Measurement of prostate-specific antigen in serum as a screening test for prostate cancer","volume":"324","author":"Catalona","year":"1991","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","article-title":"Systematic review of complications of prostate biopsy","volume":"64","author":"Loeb","year":"2013","journal-title":"Eur Urol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.juro.2017.03.130","article-title":"The value of PSA density in combination with PI-RADSTM for the accuracy of prostate cancer prediction","volume":"198","author":"Distler","year":"2017","journal-title":"J Urol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.urology.2017.07.071","article-title":"Prostate-specific antigen density is a good predictor of upstaging and upgrading, according to the new grading system: the keys we are seeking may be already in our pocket","volume":"111","author":"Brassetti","year":"2018","journal-title":"Urology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.urology.2017.04.015","article-title":"Re-examining prostate-specific antigen (PSA) density: defining the optimal PSA range and patients for using PSA density to predict prostate cancer using extended template biopsy","volume":"105","author":"Jue","year":"2017","journal-title":"Urology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/bju.13465","article-title":"Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy na\u00efve patients","volume":"119","author":"Washino","year":"2017","journal-title":"BJU Int"},{"key":"B11","doi-asserted-by":"publisher","first-page":"W166","DOI":"10.2214\/AJR.17.19253","article-title":"Combined analysis of biparametric MRI and prostate-specific antigen density: role in the prebiopsy diagnosis of gleason score 7 or greater prostate cancer","volume":"211","author":"Lee","year":"2018","journal-title":"Am J Roentgenol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.urology.2018.12.010","article-title":"Magnetic resonance imaging-defined prostate-specific antigen density significantly improves the risk prediction for clinically significant prostate cancer on biopsy","volume":"126","author":"Bhat","year":"2018","journal-title":"Urology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.1038\/s41598-024-57337-y","article-title":"PI-RADS v2.1 and PSAD for the prediction of clinically significant prostate cancer among patients with PSA levels of 4\u201310\u2005ng\/mL","volume":"14","author":"Wen","year":"2024","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"00165","DOI":"10.1016\/j.euo.2023.08.002","article-title":"Diagnostic performance of prostate-specific antigen density for detecting clinically significant prostate cancer in the era of magnetic resonance imaging: a systematic review and meta-analysis","author":"Wang","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.29271\/jcpsp.2024.10.1205","article-title":"Unlocking precision enhancing prostate cancer detection and reducing unnecessary biopsies with combined prostate-specific antigen density and PI-RADS score","volume":"34","author":"Hamidi","year":"2024","journal-title":"J Coll Physicians Surg\u2013Pak JCPSP"},{"key":"B16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/bju.15277","article-title":"Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation","volume":"127","author":"Schoots","year":"2021","journal-title":"BJU Int"},{"key":"B17","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging\u2009\u2013\u2009reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.acra.2018.03.014","article-title":"Determination of prostate volume: a comparison of contemporary methods","volume":"25","author":"Bezinque","year":"2018","journal-title":"Acad Radiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1007\/s00330-022-09239-8","article-title":"Deep learning algorithm performs similarly to radiologists in the assessment of prostate volume on MRI","volume":"33","author":"Thimansson","year":"2023","journal-title":"Eur Radiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1007\/s00330-022-08554-4","article-title":"Prostate volume prediction on MRI: tools, accuracy and variability","volume":"32","author":"Hamzaoui","year":"2022","journal-title":"Eur Radiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1067\/j.cpradiol.2021.06.006","article-title":"Deep learning network for segmentation of the prostate gland with median lobe enlargement in T2-weighted MR images: comparison with manual segmentation method","volume":"51","author":"Salvaggio","year":"2022","journal-title":"Curr Probl Diagn Radiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e230138","DOI":"10.1148\/ryai.230138","article-title":"Deep learning prostate MRI segmentation accuracy and robustness: a systematic review","volume":"6","author":"Fassia","year":"2024","journal-title":"Radiol Artif Intell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41592-020-01008-z","article-title":"nnU-net: a self-configuring method for deep learning-based biomedical image segmentation","volume":"18","author":"Isensee","year":"2021","journal-title":"Nat Methods"},{"key":"B26","doi-asserted-by":"publisher","first-page":"102241","DOI":"10.1016\/j.compmedimag.2023.102241","article-title":"Investigation and benchmarking of U-nets on prostate segmentation tasks","volume":"107","author":"Bhandary","year":"2023","journal-title":"Comput Med Imaging Graph Off J Comput Med Imaging Soc"},{"key":"B27","doi-asserted-by":"publisher","first-page":"105817","DOI":"10.1016\/j.compbiomed.2022.105817","article-title":"Prostate158\u2014an expert-annotated 3\u2005T MRI dataset and algorithm for prostate cancer detection","volume":"148","author":"Adams","year":"2022","journal-title":"Comput Biol Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.media.2013.12.002","article-title":"Evaluation of prostate segmentation algorithms for MRI: the PROMISE12 challenge","volume":"18","author":"Litjens","year":"2014","journal-title":"Med Image Anal"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1056\/NEJMoa2406050","article-title":"Results after four years of screening for prostate cancer with PSA and MRI","volume":"391","author":"Hugosson","year":"2024","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/bju.13836","article-title":"Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer","volume":"120","author":"Alberts","year":"2017","journal-title":"BJU Int"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1016\/j.acra.2020.05.014","article-title":"Prostate volume estimation on MRI: accuracy and effects of ellipsoid and bullet-shaped measurements on PSA density","volume":"28","author":"Stanzione","year":"2021","journal-title":"Acad Radiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13244-023-01394-w","article-title":"Development and clinical utility analysis of a prostate zonal segmentation model on T2-weighted imaging: a multicenter study","volume":"14","author":"Xu","year":"2023","journal-title":"Insights Imaging"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.1007\/s00330-023-09410-9","article-title":"Automated prostate multi-regional segmentation in magnetic resonance using fully convolutional neural networks","volume":"33","author":"Jimenez-Pastor","year":"2023","journal-title":"Eur Radiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13244-023-01502-w","article-title":"Label-set impact on deep learning-based prostate segmentation on MRI","volume":"14","author":"Megli\u010d","year":"2023","journal-title":"Insights Imaging"}],"container-title":["Frontiers in Digital Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2026.1897681\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:00:16Z","timestamp":1791392416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2026.1897681\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":34,"alternative-id":["10.3389\/fdgth.2026.1897681"],"URL":"https:\/\/doi.org\/10.3389\/fdgth.2026.1897681","relation":{},"ISSN":["2673-253X"],"issn-type":[{"value":"2673-253X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"1897681"}}